Laychiluh Mekonnen
0000-0001-7108-5345
Publication & Citation Trends
Publications
0 total
Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors
Cited by 0
Semantic Scholar
A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma.
Cited by 4
Semantic Scholar
Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Cited by 10
Semantic Scholar
A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer
Cited by 2
Semantic Scholar
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 OA
Cited by 17
Semantic Scholar
Cancer Burden Attributable to Potentially Modifiable Risk Factors in Australia
Cited by 2
Semantic Scholar
Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies.
Cited by 4
Semantic Scholar
2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluation.
Cited by 16
Semantic Scholar
Research Topics
Advanced Breast Cancer Therapies
(11)
Cancer-related Molecular Pathways
(9)
Chronic Lymphocytic Leukemia Research
(4)
Cancer Mechanisms and Therapy
(4)
Protein Degradation and Inhibitors
(3)
Affiliations
University of South Australia
The University of Adelaide
Bahir Dar University